A resolution recently adopted by the World Health Organization's World Health Assembly could significantly lower the incidence and impact of sepsis.
Cardiovascular disease risks persist for years after sepsis or pneumonia.
The quick Sepsis-Related Organ Failure Assessment (qSOFA) clinical tool was superior to SIRS criteria for the evaluation of in-hospital mortality.
A new organ dysfunction scoring system that predicts in-hospital mortality was validated in critically ill children admitted to the pediatric intensive care unit.
An outbreak of septic arthritis linked to intra-articular injections was identified at an outpatient practice in New Jersey.
Asthma patients with infections have a reduced risk of developing sepsis.
Rapid treatment of sepsis using mandated care bundles improves outcomes.
Sepsis is associated with pathways that lead to permanent neurological sequelae, according to research presented at the 2017 AAN annual meeting.
Researchers have updated the 2012 sepsis and septic shock management guidelines based on the results of recent clinical trials.
Compared with pro-calcitonin and C-reactive protein, presepsin has better diagnostic accuracy in discriminating early-onset sepsis.
Among medical conditions, sepsis is a leading cause of hospital readmissions and associated costs.
Using SOFA scores alone may overlook a portion of patients with sepsis at high risk for short-term mortality.
Sign Up for Free e-newsletters
Infectious Disease Advisor Articles
- Climate Change: Effects on the Incidence and Distribution of Infectious Diseases
- Improving Campaigns Regarding the Value of Adult Vaccines
- Seminal HPV Infection Prevalent Worldwide, May Affect Male Fertility
- Pausing ART to Identify Biomarkers for HIV RNA Rebound: Safety and Ethical Considerations
- MicroRNAs in Infectious Disease: Emerging Clinical Applications
- Efficacy of Direct-Acting Antivirals for HCV Clearance in Older Adults
- SVR Achieved With Sofosbuvir, Grazoprevir/Elbasvir Plus Ribavirin in HCV
- First Oral Smallpox Treatment Submitted to FDA for NDA
- Trends in Meningococcal Disease Following MenACWY Vaccine Introduction
- Clinician Accuracy Evaluated for Lyme Disease